
UoH patents nanoformulation for STI prevention and contraception
The story in brief
Researchers at the University of Hyderabad secured an Indian patent for a nanotechnology formulation on September 16, 2026. The patent covers methods and compositions using lactoferrin nanoparticles to deliver curcumin and antiretroviral drugs. The technology combines antiviral, anti-inflammatory, and contraceptive components into a single product, offering controlled drug release and potential for multifunctional use.